Breaking News Headlines Today

News from Lupin

Lupin’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

We’ve assigned a rating of Unknown factuality to Lupin. You can read more about how we’ve determined Lupin’s credibility and reliability as a news source here: https://groundnews.lakegeneva.lib.wi.us/rating-system.

Information about Lupin

Where is Lupin located?Lupin's Website Lupin's Twitter

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Lupin News

United States · United States

Lupin Launches Generic of Janssen Pharma’s VTE Drug in U.S.

100% Left coverage: 1 sources

Lupin launches Rivaroxaban for Oral Suspension in the U.S., a generic equivalent to Xarelto for VTE treatment.See the Story

Lupin Announces Presentation of Phase 1 Data on LNP3693 (STING agonist) at the ESMO Congress 2025

Global pharma company Lupin announced that it will present data from its Phase 1a clinical trial evaluating LNP3693, a STING agonist, at the European Society for Medical Oncology (ESMO) Congress in Berlin, Germany, from October 17 to October 21, 2025. The presentation, titled “A phase 1 dose escalation study of LNP3693 (STING agonist) in patients with advanced or metastatic solid tumors & lymphoma,” will be featured in the Investigational Immuno…See the Story

Mumbai · Mumbai

Lupin Launches Partnership Program Following FDA Approval of PrecisionSphere Injectable Platform

Lupin has announced the launch of a strategic partnersh […] The post Lupin Launches Partnership Program Following FDA Approval of PrecisionSphere Injectable Platform first appeared on GeneOnline News. The post Lupin Launches Partnership Program Following FDA Approval of PrecisionSphere Injectable Platform appeared first on GeneOnline News.See the Story

News from Lupin

News from Lupin

Information about Lupin

Media Bias Ratings

Factuality

Ownership

Top Lupin News

Lupin Launches Generic of Janssen Pharma’s VTE Drug in U.S.

Lupin Announces Presentation of Phase 1 Data on LNP3693 (STING agonist) at the ESMO Congress 2025

Lupin Launches Partnership Program Following FDA Approval of PrecisionSphere Injectable Platform

Similar News Topics

Topics Most Covered by Lupin

Sources Covering Similar Topics

Breaking News Topics Related to Lupin